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Abstract 
Introduction: Our aim was to assess the usefulness of fine-needle aspiration cytologic biopsy (FNA) of the thyroid in our general teaching 
hospital with average health care facility performing moderate number of such procedures and to evaluate the outcome of Indeterminate 
Cytologic Results. 
Material and method: We studied on all consecutive patients referred for FNA of the thyroid nodule. All samplings were performed 
primarily by one endocrinologist performing moderate number of samplings and interpreted by one pathologist. Cytological findings 
were classified as malignant, histologic control recommended (suspicious or indeterminate), benign, and unsatisfactory. 
Results: Four hundred and seventy six biopsies were performed. Patient acceptance of this procedure was good and no complication was 
encountered. 64/476 of samples were considered as insufficient (13.4%). Of the remaining samples (355 F, 57 M), 321 specimens (67.4%) 
were reported to be non-neoplastic lesions, including 251 (52.7%) colloid nodules, 39 (8.2%) hemorrhagic nodules and 31 (6.5%) cases of 
thyroiditis. A neoplastic nodule was confirmed in 91/476 of cases (19.1%), of which 14 were cytologically malignant (3.0%). Follicular 
lesions were identified in the remaining 77/476 cases (16.1%). Excluding 21 patients who were lost to follow-up, the remaining 56 patients 
(72.7%) were surgically followed up. Upon excision, benign lesions were diagnosed in 47/56 (83.8%), of which 32 lesions (57.1%) were 
follicular adenoma and 15 cases (26.7%) of colloid nodules. Malignancy was confirmed histopathologically in 9 cases (16.2%), including 
4 follicular variant papillary carcinomas and 5 follicular carcinomas. 
Conclusions: FNA is an inexpensive, safe, practical, well tolerated, and easily applied method, even in not fully-experienced hands and 
provides useful information. Based on our study findings, suspicious cytologic results (cytologically follicular neoplasms) are inconclusive 
and are associated with a remarkable chance of malignant involvement; hence surgical treatment is necessary for clarification. 
(Pol J Endocrinol 2008; 59 (5): 385–389) 
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Streszczenie 
Wstęp: Celem badania była ocena użyteczności biopsji aspiracyjnej cienkoigłowej tarczycy w szpitalu klinicznym przeciętnie wyposażo­
nym w sprzęt, przeprowadzającym stosunkowo rzadko takie procedury oraz ocena częstości uzyskiwania niejednoznacznych wyników 
badania cytologicznego. 
Materiał i metody: Do badania włączono wszystkich pacjentów zgłaszających się na biopsję cienkoigłową guzków tarczycy. Wszystkie 
bioptaty zostały pobrane przez jednego endokrynologa, wykonującego stosunkowo niewiele takich procedur, a następnie ocenione przez 
jednego patomorfologa. Wynik badania cytologicznego klasyfikowano następująco: zmiana złośliwa, zalecana dalsza kontrola histolo­
giczna (zmiana podejrzana lub nieokreślona), zmiana łagodna, niedostateczna ilość materiału biopsyjnego. 
Wyniki: Wykonano łącznie 476 biopsji. Akceptacja badania wśród pacjentów była dobra, nie odnotowano żadnych powikłań związanych 
z tą procedurą. Sześćdziesiąt cztery sposród 476 próbek zawierało zbyt mało materiału, aby przeprowadzić badanie (13,4%). Pozostałe 
bioptaty (355 kobiet, 57 mężczyzn) oceniono następująco: w 321 próbkach (67,4%) stwierdzono zmiany nienowotworowe, w tym 
251 (52,7%) guzków koloidowych, 39 (8,2%) guzków krwotocznych i 31 (6,5%) przypadków zapalenia tarczycy. Nowotworowy charakter 
zmian stwierdzono u 91/476 badanych (19,1%), z czego 14 miało cytologiczne cechy złośliwości (3,0%). Zmiany pęcherzykowe wykryto 
u 77/476 badanych (16,1%). Po wykluczeniu 21 osób niedostępnych do dalszej obserwacji, pozostało 56 pacjentów (72,7%), których podda­
no leczeniu chirurgicznemu. Badanie histopatologiczne wyciętych tkanek wykazało łagodny charakter zmian u 47/56 osób (83,8%), w tym 
Ali Gholamrezanezhad, M.D., Shariati Hospital, Medical Sciences, Tehran University, North Karegar St. 14114. Tehran, Iran, 
tel.: 009 891 221 070 37, e-mail: gholamrezanejhad@razi.tums.ac.ir 
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32 przypadki (57,1%) gruczolaka pęcherzykowego i 15 przypadków (26,7%) guzków koloidowych. Zmiany złośliwe potwierdzono 
u 9 (16,2%) chorych, w tym 4 przypadki raka brodawczakowego i 5 raka pęcherzykowego. 
Wnioski: Biopsja aspiracyjna cienkoigłowa jest niedrogą, bezpieczną, praktyczną, dobrze tolerowaną przez pacjentów i łatwą do prze­
prowadzenia procedurą (nawet przez lekarza nie mającego dużego doświadczenia w przeprowadzaniu tego typu procedur), a przy tym 
dostarczającą przydatnych informacji. Badanie autorów wskazuje, że wyniki badania cytologicznego określone jako zmiana podejrzana 
(zmiany pęcherzykowate) są niekonkluzywne i wiążą sie ze znacznym ryzykiem procesu złośliwego; dlatego w celu wyjaśnienia wątpli­
wości diagnostycznych konieczna jest interwencja chirurgiczna. (Endokrynol Pol 2008; 59 (5): 385–389) 
Słowa kluczowe: biopsja aspiracyjna cienkoigłowa, guzki tarczycy, zmiany pęcherzykowe 
Introduction 
Thyroid nodules are a common occurrence in the general 
population, but only a small number of them are eventu­
ally diagnosed to be malignant [1]. Thyroid fine-needle 
aspiration (FNA), in experienced hands, is the standard 
procedure for the clinical triage of thyroid nodules [2] and 
has been considered as a safe, reliable, and effective me­
thod for differentiating benign from malignant nodules 
[3]. Also it has been claimed that FNA biopsy has a sub­
stantial cost-saving effect on thyroid practice [4]. More­
over it has been confirmed that the diagnostic value of 
clinical data alone is inferior to that of FNA alone [5]. In 
spite of these advantages, there are different conclusions 
about the accuracy of the procedure, with its sensitivity 
ranging from 65% to 98% [6] and its specificity ranging 
from 55% [7] to 100% [6] in different settings. 
The adequate FNA specimen is usually categorized 
as benign, malignant, or indeterminate, cytopathologi­
cally. The latter group usually includes follicular neo­
plasm (follicular adenoma and follicular carcinoma), 
follicular variant of papillary carcinoma (FVPC) and 
sometimes a more specific diagnosis such as Hurthle 
cell neoplasm or follicular lesion/neoplasm with Hur­
thle cell change [8]. The main limitations of cytologic 
examination have been considered to be the difficulty 
in distinguishing some benign cellular adenomas from 
their malignant counterparts, arising as indeterminate, 
non-diagnostic results or cellular follicular neoplasms 
in cytologic reports [9–11], which in fact need not nega­
te continued use of FNA biopsy [11]. In fact, the cytolo­
gic differentiation of cellular colloid nodules from folli­
cular neoplasms has not been possible because of the 
scanty amount of tissue obtained by this technique and 
because of the infrequent preparation of cell blocks, 
which precludes appreciation of the tissue architecture 
[12]. The prevalence of such problem is significantly 
different among studies and populations and there is 
no data about it in regions with history of iodine defi­
ciency, which has been corrected using supplemental 
iodine (such as north of Iran). These debates remain 
until recently [13, 14]. 
Our aim was to assess the use and usefulness of fine-
needle aspiration cytologic biopsy of the thyroid in our 
general teaching hospital setting with average health 
care facility performing moderate number of such pro­
cedures and to evaluate the outcome of Indeterminate 
Cytologic Results. 
Material and methods 
Between 1997 and 2004, we conducted a study on all 
consecutive patients referred to our endocrinology de­
partment for FNA of the thyroid. All the patients had 
been selected based on the detection of a palpable soli­
tary thyroid nodule or a dominant nodule in the con­
text of a multinodular goiter. All the patients gave in­
formed consent to participate in the study. 
Fine needle aspiration 
All thyroid aspirations were performed by an endocri­
nologist performing moderate number of such proce­
dures (about 100 FNA/year). After localizing the nodu­
le by palpation, the FNA was performed using a 25-gau­
ge needle attached to a 20-ml syringe. On average, 
4 passes were made in each nodule, resulting in six al­
chohol-fixed smears. Subsequently all smears were sta­
ined by modified Papanicolaou technique and were 
analyzed and interpreted by a blinded pathologist. The 
results of the cytopathologic analysis were reported 
based on the following categories: benign, malignant, 
histologic control recommended (indeterminate or su­
spicious) and insufficient. The adequate FNA specimen 
was defined as containing at least 8–10 cell groups on 2 
slides, with 8–10 follicular cells in each group [15]. 
All patients with follicular lesion were advised to 
undergo lobectomy to accurately determine the nature 
of the neoplasm and the post-operative pathology re­
sults were recorded. 
Statistical analysis 
A descriptive analysis was done on all variables to obtain 
a frequency distribution. The quantitative variables were 
expressed as the mean ± SD and range. Statistical analysis 
was performed using SPSS software package version 15.0. 
Results 
Four hundred and seventy six patients entered in the 
study and underwent FNA of the dominant (or the 
386
 
Endokrynologia Polska/Polish Journal of Endocrinology 2008; 59 (5) 
PR
A
C
E 
O
R
Y
G
IN
A
LN
E

 
solitary) thyroid nodule. The mean age ± SD of the par­
ticipants was 38.37 ± 9.81yrs (age range: 14–75 yr). No 
complication was found among the studied patients and 
patient acceptance has been high. 
Out of 476 samples, 64 cases were considered as in­
sufficient for cytopathological analysis (13.4%). These 
were excluded from the series, leaving 412 cases. Of the 
remaining samples (355 F, 57 M), 321 specimens (67.4%) 
were reported to be non-neoplastic lesions, including 
251 (52.7%) colloid nodules, 39 (8.2%) hemorrhagic no­
dules and 31 (6.5%) cases of thyroiditis. A neoplastic 
nodule was confirmed in 91/476 of cases (19.1%), of 
which 14 were cytologically malignant (3.0%, including 
both papillary lesions and FVPC). Follicular lesions were 
identified in the remaining 77/476 cases (16.1%). 
In spite of the fact that all patients with follicular 
lesion were advised to undergo lobectomy to accurate­
ly determine the nature of the neoplasm, only 56 pa­
tients (72.7%) received surgical treatment. Upon exci­
sion in this subgroup of patients, benign lesions were 
diagnosed in 47/56 patients (83.8%), of which 32 lesions 
(57.1%) were follicular adenoma and 15 cases (26.7%) 
of colloid nodules. Thyroid malignancy was confirmed 
histopathologically in 9 cases (16.2%), including 4 FVPC 
and 5 follicular carcinomas. Finally, based on the FNA 
analysis (both cytologically malignant and indetermi­
nate reports with subsequent surgical resection), 23/391 
(5.9%) of adequate samples were malignant (excluding 
those patients who did not undergo surgical resection). 
Discussion 
There are some confirmed facts that prove the utility of 
FNA in the routine practice and management of thyro­
id nodules: 
1.	 The cancer removal rate is higher with FNA and 
surgery than with surgery alone [16]. 
2.	 The percentage of patients operated on decreases 
from 95% to 60% [17]. 
3.	 FNA is of great value since it enables greater cancer 
detection in a cost-effective manner [16, 17]. 
4.	 It can be performed even without the guidance of 
ultrasonography, successfully [18]; however, ultra­
sonographically-guided FNA is superior to palpa­
tion-guided FNA for obtaining adequate material 
especially for small-sized nodules, as well as provi­
ding more accurate cytologic evaluation [19]. Inde­
ed, the difference between the costs of two proce­
dures might be acceptable [19]. 
5.	 As it was confirmed in our study, there is no remar­
kable side effect or complications in this procedure. 
In our study, 13.4% of the samples were diagnosti­
cally insufficient. This rate compares very favorably with 
major referral centers [20–22], especially highly develo­
ped countries [23, 24] and even lower than their failure 
rates [25–27]. Although it has been stated that the fre­
quency of inadequate smears, in turn, is strongly rela­
ted to the type of physician performing the aspiration 
[27] and the frequency was highest among communi­
ty-based clinicians (32.4%) [27], based on our findings 
it seems that FNA of thyroid nodules even in the hands 
of not fully expert endocrinologists performing mode­
rate numbers of such procedure and also without the 
guidance of ultrasonography (in developing countries 
and in general hospital settings) can be as efficacious as 
highly developed and equipped situations. Previously 
similar conclusions were drawn: It has been stated that 
FNA is a well tolerated, and easily applied procedure 
without its highly desirable features being compromi­
sed, even when a moderate number of such procedu­
res are performed [28]. Although Haas et al [29] and 
other groups [30, 31] have shown that the incidence of 
inadequate specimens decreases inversely from 18% to 
6% with the increase in the experience of operator and 
hence, it can be concluded that our experience in blind 
aspiration of nodules is borderline (with 13.4% failure 
rate), however, our failure rate is lower than many de­
veloping countries with full experience on this proce­
dure [31]. Fitz-Patrick et al stated that when an expe­
rienced endocrinologist and cytopathologist are availa­
ble, aspiration biopsy is the diagnostic procedure of 
choice [32]; however, in our opinion FNA can be the 
procedure of choice even in the hands of inexperien­
ced physicians. In fact, we are in agreement with Si­
lverman et al conclusion in that special referral centers 
are not needed to interpret the cytologic material and 
well trained surgical pathologists can become proficient 
in interpreting the FNA biopsies without significant loss 
in accuracy, thereby render a definite diagnosis in the 
vast majority of the cases [33]. These conclusions are 
against the statement of Friedman [34] and also Wil­
lems and Löwhagen [35] that interpretation requires an 
experienced cytologist and endocrinologist. 
In our study the frequencies of all three subgroups 
of benign, suspicious and malignant FNA cytologic re­
sults are in the range of those reported in the literature 
[6, 36]. For example, based on the comprehensive re­
view of Gharib and Goellner, rates for four main cyto­
logic categories, based on data pooled from seven large 
series, were as follows: benign, 69%; suspicious, 10%; 
malignant, 4%; and nondiagnostic, 17% [6]. However, 
in the study of Kumar et al on patients from an iodine 
deficient region, FNA cytology was positive for mali­
gnancy in 6.2% of patients [37], which is higher than 
our results. The etiologic significance of this difference 
and its relationship to iodine deficiency and measures 
performed in our country to overcome iodine deficien­
cy needs to be further evaluated. 
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On the other hand, in our population the frequency 
of malignancy among those who has been cytological­
ly categorized as follicular neoplasm (16.2%) was lower 
than that of few other populations [8, 38], while higher 
than others [39]. For example, in the study of McHenry 
et al pathologic evaluation of these cases revealed can­
cer in 9%, adenoma in 43%, colloid nodule in 45%, epi­
thelial cyst in 2%, and thyroiditis in 1% of cases [39]. As 
another example, Piromalli et al stated that in their stu­
dy on 795 Italian cases, all patients with cytological dia­
gnosis of follicular tumor had a benign lesion at histo­
logy [40]. Moreover, McHenry et al stated the “nondia­
gnostic” cytology is a significant limitation of FNAB as­
sociated with a 52% neoplasia rate and a 9% incidence 
of malignancy [39]. Based on these differences, it seems 
that the prevalence of malignancy in cytologically folli­
cular lesions depends on geographic, nutritional, eth­
nicity, and other factors. According to these facts and 
also based on the conclusion of Layfield et al [41] that 
stated once an aspiration diagnosis of “follicular neo­
plasm” had been made, no clinical, radiologic, or labo­
ratory test aided in the distinction of follicular adeno­
ma from follicular carcinoma, it seems necessary to per­
form histologic evaluation on all patients with non-dia­
gnostic cytology. Similarly, in previous studies it has 
been advised that in order to avoid a missed carcino­
ma, surgical treatment of persistent “non-diagnostic” 
FNA in a dominant hypofunctioning nodule is indica­
ted [39]. Similar to our study, Tamez-Pérez et al evalu­
ated the definitive histological results of a group of 41 
patients with FNA of thyroid nodule catalogued as “in­
determinate/non diagnostic” sent for surgical treat­
ment. Finally they found that the majority of patients 
with a diagnosis of “indeterminated/non diagnostic” 
had benign lesions (60.9%). The usual predictive fac­
tors for malignity such as age, sex, size of nodule, did 
not present a significant support in the differential dia­
gnosis [42] and hence surgical intervention seems to 
be necessary. 
Study limitations 
1.	 In our study, for inadequate samples and also those 
with cytologic diagnosis of follicular lesion, repeated 
aspiration did not performed, as numerous papers 
in this field failed to reveal any advantage [21, 43]. 
2.	 In our study only 72.7% of those patients who requ­
ired surgical intervention underwent thyroid sur­
gery. Although this rate seems to be low, it is even 
considerably higher than the same rate in even deve­
loped countries [44]. In the study of Maxwell et al [44], 
in 21 patients the FNA gave indication for thyroid 
surgery, yet surgery was done in only 12 (57.1%). 
Fortunately, this finding emphasizes on the fact that 
the patient’s motivation and also medical follow-ups 
in the developing regions are effective enough. 
3.	 In our study, FNA samplings were not done using 
ultrasonography (US)-guided method, as there were 
limitations in US facilities. Although Yokozawa et al 
reported that this limitation would increase the pro­
bability of palpable cancers with insufficient cell 
material for analysis or cancers with calcified lesions 
[36], some other previous reports concluded that in 
palpable nodules sensitivity, specificity, accuracy, 
and positive and negative predictive values of US-
guided FNA for malignancy were not significantly 
different from those of palpation-guided FNA [18]. 
Conclusion 
From the results of this study and other studies in the 
literature, it can be concluded that FNA is an inexpen­
sive, safe, practical, well tolerated, and easily applied 
method, even in not fully-experienced hands and pro­
vides useful information for further clinical decision 
about thyroid nodules (although in some cases surgical 
exploration is required for diagnosis). Based on our stu­
dy findings, suspicious cytologic results (cytologically 
follicular neoplasms) are inconclusive and are associa­
ted with a remarkable chance of malignant involvement; 
hence surgical treatment is necessary for clarification. 
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